Literature DB >> 25572304

Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.

Laetitia Seguin1, Jay S Desgrosellier1, Sara M Weis1, David A Cheresh2.   

Abstract

Interactions between cancer cells and their surroundings can trigger essential signaling cues that determine cell fate and influence the evolution of the malignant phenotype. As the primary receptors involved in cell-matrix adhesion, integrins present on the surface of tumor and stromal cells have a profound impact on the ability to survive in specific locations, but in some cases, these receptors can also function in the absence of ligand binding to promote stemness and survival in the presence of environmental and therapeutic stresses. Understanding how integrin expression and function is regulated in this context will enable the development of new therapeutic approaches to sensitize tumors to therapy and suppress their metastatic phenotype.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; drug resistance; integrins; stemness

Mesh:

Substances:

Year:  2015        PMID: 25572304      PMCID: PMC4380531          DOI: 10.1016/j.tcb.2014.12.006

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  66 in total

1.  Integrin alpha 6 regulates glioblastoma stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

2.  Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary gland.

Authors:  Jay S Desgrosellier; Jacqueline Lesperance; Laetitia Seguin; Maricel Gozo; Shumei Kato; Aleksandra Franovic; Mayra Yebra; Sanford J Shattil; David A Cheresh
Journal:  Dev Cell       Date:  2014-08-11       Impact factor: 12.270

Review 3.  Tetraspanins at a glance.

Authors:  Stéphanie Charrin; Stéphanie Jouannet; Claude Boucheix; Eric Rubinstein
Journal:  J Cell Sci       Date:  2014-08-15       Impact factor: 5.285

Review 4.  Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration.

Authors:  Cédric Blanpain; Elaine Fuchs
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

Review 5.  Integrins in cancer: biological implications and therapeutic opportunities.

Authors:  Jay S Desgrosellier; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

6.  Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis.

Authors:  S Cagnet; M M Faraldo; M Kreft; A Sonnenberg; K Raymond; M A Glukhova
Journal:  Oncogene       Date:  2013-09-30       Impact factor: 9.867

Review 7.  The final steps of integrin activation: the end game.

Authors:  Sanford J Shattil; Chungho Kim; Mark H Ginsberg
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04       Impact factor: 94.444

Review 8.  Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis.

Authors:  Martin Schlesinger; Gerd Bendas
Journal:  Int J Cancer       Date:  2014-05-06       Impact factor: 7.396

Review 9.  Integrins as novel drug targets for overcoming innate drug resistance.

Authors:  Jason S Damiano
Journal:  Curr Cancer Drug Targets       Date:  2002-03       Impact factor: 3.428

10.  Induction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture.

Authors:  Shabnam Ziaee; Leland W K Chung
Journal:  Mol Cancer       Date:  2014-09-08       Impact factor: 27.401

View more
  261 in total

Review 1.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

2.  Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.

Authors:  R Sayroo; D Nolasco; Z Yin; Y Colon-Cortes; M Pandya; C Ling; G Aslanidi
Journal:  Gene Ther       Date:  2015-10-08       Impact factor: 5.250

3.  MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling.

Authors:  I Lakshmanan; S Rachagani; R Hauke; S R Krishn; S Paknikar; P Seshacharyulu; S Karmakar; R K Nimmakayala; G Kaushik; S L Johansson; G B Carey; M P Ponnusamy; S Kaur; S K Batra; A K Ganti
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

4.  ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.

Authors:  Tomasz B Owczarek; Takashi Kobayashi; Ricardo Ramirez; Lijie Rong; Anna M Puzio-Kuter; Gopa Iyer; Min Yuen Teo; Francisco Sánchez-Vega; Jingqiang Wang; Nikolaus Schultz; Tian Zheng; David B Solit; Hikmat A Al-Ahmadie; Cory Abate-Shen
Journal:  Cancer Res       Date:  2017-01-12       Impact factor: 12.701

5.  Biophysical Regulation of Cancer Stem/Initiating Cells: Implications for Disease Mechanisms and Translation.

Authors:  Joseph Chen; Sanjay Kumar
Journal:  Curr Opin Biomed Eng       Date:  2017-05-19

6.  Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway.

Authors:  Shaojia Wang; Jiajia Li; Jie Xie; Fei Liu; Yachen Duan; Yong Wu; Shenglin Huang; Xianghuo He; Ziliang Wang; Xiaohua Wu
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

7.  Elucidating the role of Agl in bladder carcinogenesis by generation and characterization of genetically engineered mice.

Authors:  Joseph L Sottnik; Vandana Mallaredy; Ana Chauca-Diaz; Carolyn Ritterson Lew; Charles Owens; Garrett M Dancik; Serena Pagliarani; Sabrina Lucchiari; Maurizio Moggio; Michela Ripolone; Giacomo P Comi; Henry F Frierson; David Clouthier; Dan Theodorescu
Journal:  Carcinogenesis       Date:  2019-03-12       Impact factor: 4.944

8.  Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.

Authors:  Tomoyo Okada; Ann Y Lee; Li-Xuan Qin; Narasimhan Agaram; Takahiro Mimae; Yawei Shen; Rachael O'Connor; Miguel A López-Lago; Amanda Craig; Martin L Miller; Phaedra Agius; Evan Molinelli; Nicholas D Socci; Aimee M Crago; Fumi Shima; Chris Sander; Samuel Singer
Journal:  Cancer Discov       Date:  2016-08-30       Impact factor: 39.397

9.  AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells.

Authors:  Petreena S Campbell; Nicole Mavingire; Salma Khan; Leah K Rowland; Jonathan V Wooten; Anna Opoku-Agyeman; Ashley Guevara; Ubaldo Soto; Fiorella Cavalli; Andrea Irene Loaiza-Pérez; Gayathri Nagaraj; Laura J Denham; Olayemi Adeoye; Brittany D Jenkins; Melissa B Davis; Rachel Schiff; Eileen J Brantley
Journal:  J Cell Physiol       Date:  2018-08-04       Impact factor: 6.384

10.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.